GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Teva Pharmaceutical Industries Ltd (MEX:TEVA N) » Definitions » Cyclically Adjusted Book per Share

Teva Pharmaceutical Industries (MEX:TEVA N) Cyclically Adjusted Book per Share : MXN351.23 (As of Mar. 2025)


View and export this data going back to 2011. Start your Free Trial

What is Teva Pharmaceutical Industries Cyclically Adjusted Book per Share?

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Book per Share and the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years.

Teva Pharmaceutical Industries's adjusted book value per share for the three months ended in Mar. 2025 was MXN111.695. Add all the adjusted book value per share for the past 10 years together and divide the count will get our Cyclically Adjusted Book per Share, which is MXN351.23 for the trailing ten years ended in Mar. 2025.

During the past 12 months, Teva Pharmaceutical Industries's average Cyclically Adjusted Book Growth Rate was -13.00% per year. During the past 3 years, the average Cyclically Adjusted Book Growth Rate was -8.50% per year. During the past 5 years, the average Cyclically Adjusted Book Growth Rate was -6.20% per year. During the past 10 years, the average Cyclically Adjusted Book Growth Rate was -1.80% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Cyclically Adjusted Book Growth Rate using Cyclically Adjusted Book per Share data.

During the past 13 years, the highest 3-Year average Cyclically Adjusted Book Growth Rate of Teva Pharmaceutical Industries was 29.10% per year. The lowest was -8.50% per year. And the median was 20.70% per year.

As of today (2025-05-28), Teva Pharmaceutical Industries's current stock price is MXN325.00. Teva Pharmaceutical Industries's Cyclically Adjusted Book per Share for the quarter that ended in Mar. 2025 was MXN351.23. Teva Pharmaceutical Industries's Cyclically Adjusted PB Ratio of today is 0.93.

During the past 13 years, the highest Cyclically Adjusted PB Ratio of Teva Pharmaceutical Industries was 3.25. The lowest was 0.23. And the median was 0.58.


Teva Pharmaceutical Industries Cyclically Adjusted Book per Share Historical Data

The historical data trend for Teva Pharmaceutical Industries's Cyclically Adjusted Book per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Teva Pharmaceutical Industries Cyclically Adjusted Book per Share Chart

Teva Pharmaceutical Industries Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Cyclically Adjusted Book per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only 540.83 504.86 443.43 337.32 351.56

Teva Pharmaceutical Industries Quarterly Data
Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25
Cyclically Adjusted Book per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 330.91 346.37 354.66 351.56 351.23

Competitive Comparison of Teva Pharmaceutical Industries's Cyclically Adjusted Book per Share

For the Drug Manufacturers - Specialty & Generic subindustry, Teva Pharmaceutical Industries's Cyclically Adjusted PB Ratio, along with its competitors' market caps and Cyclically Adjusted PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Teva Pharmaceutical Industries's Cyclically Adjusted PB Ratio Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Teva Pharmaceutical Industries's Cyclically Adjusted PB Ratio distribution charts can be found below:

* The bar in red indicates where Teva Pharmaceutical Industries's Cyclically Adjusted PB Ratio falls into.


;
;

Teva Pharmaceutical Industries Cyclically Adjusted Book per Share Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Book per Share and the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years.

What is Cyclically Adjusted Book per Share? How do we calculate Cyclically Adjusted Book per Share?

Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the Cyclically Adjusted Book per Share of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the book value per share from 2001 through 2010.

We adjusted the 2001 book value per share data with the total inflation from 2001 through 2010 to the equivalent book value in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart's book value is $1 a share in 2001, then the 2001's equivalent book value in 2010 is $1.4 a share. If Wal-Mart's book value is $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 book value in 2010 is $1.35. So on and so forth, you get the equivalent book value per share of past 10 years. Then you add them together and divided the sum by the count to get Cyclically Adjusted Book per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Teva Pharmaceutical Industries's adjusted Book Value per Share data for the three months ended in Mar. 2025 was:

Adj_Book= Book Value per Share /CPI of Mar. 2025 (Change)*Current CPI (Mar. 2025)
=111.695/134.9266*134.9266
=111.695

Current CPI (Mar. 2025) = 134.9266.

Teva Pharmaceutical Industries Quarterly Data

Book Value per Share CPI Adj_Book
201506 425.260 100.684 569.891
201509 450.990 100.392 606.132
201512 501.606 99.792 678.208
201603 505.026 100.470 678.224
201606 536.797 101.688 712.258
201609 600.239 101.861 795.086
201612 603.627 101.863 799.560
201703 563.443 102.862 739.081
201706 433.646 103.349 566.143
201709 447.466 104.136 579.774
201712 265.136 104.011 343.943
201803 266.357 105.290 341.332
201806 273.665 106.317 347.308
201809 255.243 106.507 323.351
201812 265.077 105.998 337.421
201903 261.792 107.251 329.348
201906 248.435 108.070 310.175
201909 249.286 108.329 310.491
201912 241.270 108.420 300.256
202003 289.610 108.902 358.821
202006 291.787 108.767 361.964
202009 193.362 109.815 237.579
202012 181.883 109.897 223.308
202103 185.431 111.754 223.880
202106 186.338 114.631 219.329
202109 195.123 115.734 227.480
202112 191.097 117.630 219.197
202203 167.558 121.301 186.380
202206 163.706 125.017 176.683
202209 158.780 125.227 171.079
202212 136.958 125.222 147.572
202303 126.451 127.348 133.976
202306 107.883 128.729 113.077
202309 107.671 129.860 111.872
202312 113.647 129.419 118.483
202403 106.642 131.776 109.192
202406 102.830 132.554 104.671
202409 105.398 133.029 106.902
202412 98.830 133.157 100.143
202503 111.695 134.927 111.695

Add all the adjusted book value per share together and divide the count will get our Cyclically Adjusted Book per Share.


Teva Pharmaceutical Industries  (MEX:TEVA N) Cyclically Adjusted Book per Share Explanation

If a company grows much fast than inflation, Cyclically Adjusted Book per Share may underestimate the company's equity. Cyclically Adjusted PB Ratio can seem to be too high even the actual PB Ratio is low.

For the Cyclically Adjusted PB Ratio, the book value of the past 10 years are inflation-adjusted and averaged. The result is used for P/B calculation. Since it looks at the average over the last 10 years, the Cyclically Adjusted PB Ratio is also called CAPB Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted book value per share of a company over the past 10 years.

Teva Pharmaceutical Industries's Cyclically Adjusted PB Ratio of today is calculated as

Cyclically Adjusted PB Ratio=Share Price/Cyclically Adjusted Book per Share
=325.00/351.23
=0.93

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

During the past 13 years, the highest Cyclically Adjusted PB Ratio of Teva Pharmaceutical Industries was 3.25. The lowest was 0.23. And the median was 0.58.


Be Aware

Cyclically Adjusted PB Ratio works better for cyclical companies. It gives you a better idea on the company's real book value.


Teva Pharmaceutical Industries Cyclically Adjusted Book per Share Related Terms

Thank you for viewing the detailed overview of Teva Pharmaceutical Industries's Cyclically Adjusted Book per Share provided by GuruFocus.com. Please click on the following links to see related term pages.


Teva Pharmaceutical Industries Business Description

Address
124 Dvora HaNevi’a Street, Tel Aviv, ISR, 6944020
Teva Pharmaceutical Industries, based in Israel, is the leading generic drug manufacturer in the world. Teva derives half of its sales from North America and makes up a high-single-digit percentage of the total number of generic prescriptions in the US. It also has a significant presence in Europe, Japan, Russia, and Israel. Besides generics, Teva has a portfolio of innovative medicines and biosimilars in three main therapeutic areas: the central nervous system with Copaxone, Ajovy, and Austedo; respiratory with Qvar and ProAir; and oncology with Truxima, Herzuma, and Bendeka/Treanda. Teva also sells active pharmaceutical ingredients, offers contract manufacturing services, and owns Anda, a US-based generic and specialty drug distributor.

Teva Pharmaceutical Industries Headlines

No Headlines